Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. - Wikidata - awgldk - TriplyDB

Hyperuricemia and urate nephropathy in urate oxidase-deficient mice.

Hyperuricemia and urate nephropathy in urate oxidase-deficient mice.

http://www.wikidata.org/entity/Q34997786

about

Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol Aortic wall damage in mice unable to synthesize ascorbic acid Urate oxidase knockdown decreases oxidative stress in a murine hepatic cell line Hyperuricemia: A Biomarker of Renal Hemodynamic Impairment Renal transport of uric acid: evolving concepts and uncertainties Uric acid, hyperuricemia and vascular diseases Recent applications of engineered animal antioxidant deficiency models in human nutrition and chronic disease A mouse model of early-onset renal failure due to a xanthine dehydrogenase nonsense mutation Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice Catalysis and Structure of Zebrafish Urate Oxidase Provide Insights into the Origin of Hyperuricemia in Hominoids Pxmp2 is a channel-forming protein in Mammalian peroxisomal membrane.Impulsivity is associated with uric acid: evidence from humans and mice Gout: questions that still need to be answered The role of uric acid in kidney fibrosis: experimental evidences for the causal relationship.Oral uricase eliminates blood uric acid in the hyperuricemic pig model.Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats.Uric acid transport and disease High-yield expression, purification, characterization, and structure determination of tag-free Candida utilis uricase.Uric acid: a novel mediator and marker of risk in chronic kidney disease?Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo.Oral microencapsulated live Saccharomyces cerevisiae cells for use in renal failure uremia: preparation and in vivo analysis.Uric acid and evolution.Progressive renal papillary calcification and ureteral stone formation in mice deficient for Tamm-Horsfall protein Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease.Theobromine inhibits uric acid crystallization. A potential application in the treatment of uric acid nephrolithiasis Multiple organic anion transporters contribute to net renal excretion of uric acid The mousetrap: what we can learn when the mouse model does not mimic the human disease.Characterization of the complete uric acid degradation pathway in the fungal pathogen Cryptococcus neoformans Integrative physiology and functional genomics of epithelial function in a genetic model organism.Allopurinol reduces the lethality associated with acute renal failure induced by Crotalus durissus terrificus snake venom: comparison with probenecid.Contribution of xanthine oxidoreductase to mammary epithelial and breast cancer cell differentiation in part modulates inhibitor of differentiation-1.Decreased urine uric acid excretion is an independent risk factor for chronic kidney disease but not for carotid atherosclerosis in hospital-based patients with type 2 diabetes: a cross-sectional study Uric acid stones in the urinary bladder of aryl hydrocarbon receptor (AhR) knockout mice.Uricases as therapeutic agents to treat refractory gout: Current states and future directions.The renal phenotype of allopurinol-treated HPRT-deficient mouse.Silkworms can be used as an animal model to screen and evaluate gouty therapeutic drugs Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice.

P2860

Q24298283-B79265CD-0C42-4391-993D-42169B7D5270 Q24559986-1935BF98-43A5-47DB-9715-6448D1AED421 Q24652967-7F85067F-0525-4CE8-9446-9671825392AF Q24678375-5EEFD99D-05F9-4DA6-997A-353F13D84DFB Q24704730-E9480415-5691-47A2-92C1-F47D4DF5EC23 Q26801451-EC30ABBA-294F-42FB-AF35-671251053349 Q26829446-C0C89D8F-8F1E-4111-9A5E-D71C41A7FF43 Q26850727-860A429E-E8DE-49C1-8C24-C155815E5216 Q26859354-61DA3E87-9231-45C4-8488-2F183598FC97 Q28483790-D4C74614-FD44-4B83-BE39-0D308C600341 Q28587434-45DC7FD2-C2D5-4AE2-BC0C-FF4EF1CAE348 Q28589525-DB881DC2-D676-41A7-BDC1-79573A439593 Q29871130-2DFF8CEF-16BE-46C3-A173-E3EDBEE1881C Q30559234-9E1BFAE1-5AA8-4F04-A0E2-0C9C49B331C9 Q33566972-858C218F-75FC-48CF-AC7F-950FA85D28F1 Q33634704-C1FADD48-23E5-4BD4-B81A-81817744A05E Q33778745-ECDB4DD4-528F-4D11-9BA6-6AF1D11E8CA0 Q33779697-D74F8267-6290-4B45-96B8-0EF28AB3B8C6 Q33882958-CC385A42-A409-479D-B39B-B210BA0267D8 Q33901052-DF8123AE-2075-4A53-A33C-7403C4440EC1 Q33913892-137694FF-D7F9-4FD2-ACE9-6D25E83C6FF6 Q34069534-35AC74F2-99FA-4D92-8AB4-13050771053F Q34080384-A018ED23-15B5-444B-9C65-1A1D09F2E1E2 Q34125842-CCF60202-04C3-445C-B2CE-18DAD48D2999 Q34149642-EC8B197C-265C-4AD6-95AD-F19A236F3AC0 Q34273978-B1164FB5-896E-4406-83B1-C33D602D8CF4 Q34380395-89C29AC6-19B6-462F-98DE-65204E8859B3 Q34470733-DBDEF9CA-1A52-4E23-B5AF-05F9D121485E Q34578759-3C569C65-0E88-46AE-83C0-3A50A6C2211D Q34718544-64473223-06BB-48EC-B69B-4F39A6B246D1 Q35169902-89E138AC-4B0F-45FE-B21F-5BEB6DA8E9BB Q35198815-A7F4FCEA-3BB4-42DF-A375-53484B1165D5 Q35219040-45FD0284-2C68-4B67-B7F8-55FCE28B5789 Q35518966-585C3497-0165-450A-9F36-E5B97EB6EA61 Q35708926-8A972C4A-65E0-4475-8311-1B252B12F8DB Q36002499-82AFE62B-03AD-47F7-857E-CCA53EFDF6C0 Q36304281-58E5A09F-F07E-4F63-B51B-128B6D3AF4FB Q36305737-44DBF08A-8578-4277-9CD3-4D01BFF6080A Q36512151-BEE7DBF4-DD04-4FAD-90BA-6E75AEB0DD0A Q36546979-A54FFB05-64C1-4FD9-967F-4CC220DBC178

P2860

Hyperuricemia and urate nephropathy in urate oxidase-deficient mice.

http://www.wikidata.org/entity/Q34997786

description

1994 nî lūn-bûn

@nan

1994 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Hyperuricemia and urate nephropathy in urate oxidase-deficient mice.

@ast

Hyperuricemia and urate nephropathy in urate oxidase-deficient mice.

@en

Hyperuricemia and urate nephropathy in urate oxidase-deficient mice.

@nl

type

label

Hyperuricemia and urate nephropathy in urate oxidase-deficient mice.

@ast

Hyperuricemia and urate nephropathy in urate oxidase-deficient mice.

@en

Hyperuricemia and urate nephropathy in urate oxidase-deficient mice.

@nl

prefLabel

Hyperuricemia and urate nephropathy in urate oxidase-deficient mice.

@ast

Hyperuricemia and urate nephropathy in urate oxidase-deficient mice.

@en

Hyperuricemia and urate nephropathy in urate oxidase-deficient mice.

@nl

P1433

Q34997786-8CD90394-AFF4-4A02-800F-6FAEF185900D

P1476

Q34997786-47A14F20-772D-4857-8BBA-F6ED78EBC01F

P2093

Q34997786-10664B9C-BB43-4C77-A044-30C7C3D7AF12

Q34997786-4FF59052-1654-4391-9068-54B39A5EECDD

Q34997786-686F54B8-67A5-4A7A-A0EF-F3F4AC81C6D7

Q34997786-6D0874FC-C025-471E-8C6A-080D62AC2C45

Q34997786-8FD1E433-B0FC-40A1-9D49-53B1B61EEB8B

Q34997786-9AF9A09F-34C6-4BC0-ACCC-DF2D0AFEB1A1

Q34997786-A3B040F6-7F4E-4C09-AC8B-FD493CB115A0

Q34997786-A86864F8-92C2-41CD-A7FD-007250EDAD6F

P2860

Q34997786-1789547A-8004-4833-B57B-DA16E286CEF9

Q34997786-1FF1936D-36C1-42FB-9C9F-78FA831E31E0

Q34997786-24E434C9-7F93-4E1D-9FE1-B74154DF5251

Q34997786-31E5AD9C-9EE8-4D81-8AE2-DDF133BE77E4

Q34997786-354E8DF0-FF50-4A04-B630-54805F743CBE

Q34997786-BA7F60FF-21D4-4EDC-96BE-1A7E8C35E6CF

Q34997786-D70A6117-1390-4F9C-A502-8D54C4079E5C

Q34997786-DD8011AA-1038-46CC-A87F-482A86312DCC

P304

Q34997786-9BBE4C31-EE9B-46E0-B028-ED58A34C1E93

P31

Q34997786-7DAE1F8E-148A-4205-AC81-FE27B4268D59

P356

Q34997786-138D9C8D-B9F0-4748-A04F-086A52993ECA

P407

Q34997786-B6CEEACD-B4EE-475B-A8DA-18886C998FD0

P433

Q34997786-3524A923-AD23-4FCE-BD0B-155757F11C4D

P478

Q34997786-93B47281-5F4E-4603-8C32-4C986A297418

P577

Q34997786-FE62D43D-139A-4107-AD13-DDBD605B7B3B

P5875

Q34997786-B92ED7D3-309D-4D31-86A4-A05592083987

P698

Q34997786-580853C6-6563-4469-9893-99AFF897ED31

P932

Q34997786-F313EFEE-D548-4F30-8347-1B5E7EEA12B4

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Hyperuricemia and urate nephropathy in urate oxidase-deficient mice.

@en

P2093

Bradley A

http://www.w3.org/2001/XMLSchema#string

Caskey CT

http://www.w3.org/2001/XMLSchema#string

Geske R

http://www.w3.org/2001/XMLSchema#string

Jones P

http://www.w3.org/2001/XMLSchema#string

Montgomery C Jr

http://www.w3.org/2001/XMLSchema#string

Vaishnav S

http://www.w3.org/2001/XMLSchema#string

Wakamiya M

http://www.w3.org/2001/XMLSchema#string

Wu X

http://www.w3.org/2001/XMLSchema#string

P2860

Urate oxidase: primary structure and evolutionary implications

Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis

The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain

Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes

Two independent mutational events in the loss of urate oxidase during hominoid evolution.

On the loss of uricolytic activity during primate evolution--I. Silencing of urate oxidase in a hominoid ancestor.

Disorders associated with hyperuricemia.

The enzymatic spectrophotometric method for determination of uric acid.

P304

742-746

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.91.2.742

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P577

1994-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14907891

http://www.w3.org/2001/XMLSchema#string

P698

8290593

http://www.w3.org/2001/XMLSchema#string

P932

43025

http://www.w3.org/2001/XMLSchema#string